The forecasted respiratory system disease mortality for U.S. women exhibits a gradual decline from 2024 to 2028. The standardized rate decreases from 71.9 deaths per hundred thousand women in 2024 to 69.7 in 2028. Though 2023 data is absent, the consistent year-on-year decrease suggests potential improvements in healthcare or prevention methods. The compound annual growth rate (CAGR) over these five years indicates a steady decline, reflecting enhanced surveillance and treatment interventions in respiratory health.
Future trends to watch include breakthroughs in treatment, the impact of emerging respiratory diseases, and changes in healthcare policy and accessibility. Monitoring these factors is crucial for accurate future forecasts.
